Why the study?
Does PVI plus CFAEs ablation reduce AF recurrence compared to PVI alone in patients with paroxysmal AF and type 1 diabetes mellitus?
Does PVI plus CFAEs ablation reduce AF recurrence compared to PVI alone in patients with paroxysmal AF and type 1 diabetes mellitus?
In patients with paroxysmal AF and type 1 diabetes, adding CFAE ablation to PVI does not significantly reduce overall 1-year recurrence but may benefit those with poor glycemic control, long diabetes history, or high AF burden.
Authors
No takes yet. Share an insight, caveat, or question.
Does not support adding CFAE ablation to PVI in type 1 DM paroxysmal AF; leaves open targeted ablation for fibrotic substrates.
Grieco et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: